Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Randomized 12-week study of visual field change with pregabalin vs placebo in partial epilepsy
2009-014269-25Phase 4Completed
- Sponsor
- Pfizer
- Start
- Oct 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in Focal Onset Epilepsy comparing Pregabalin with Placebo (2 arms). Primary endpoint: Visual field threshold deterioration (primary). Started Oct 2009; status: completed.
02
Drugs
pregabalin
03
Conditions
Focal Onset Epilepsy
Beyond the preview
Go deeper on 2009-014269-25.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-014269-25.